4
Changes in Ownership
Vera Therapeutics, Inc. Filed Acc 0001209191-22-049176
Chief Development Officer sold 988 shares at $18.63 ($18,406)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curley Joanne Chief Development Officer | 2022-09-07 | Sale | −988 | $18.63 | $18,406 | 28,797 | D: show line 1 in the form |
| Open-market sales · 988 sh · avg $18.63 · $18,406 | |||||||
Loading xslF345X03/doc4.xml…